BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26725021)

  • 1. Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain.
    Menor Almagro R; Jurado Roger A; Rodríguez Gutiérrez FJ; Solís Díaz R; Cardiel MH; Salaberri Maestrojuan JJ
    Reumatol Clin; 2016; 12(5):256-62. PubMed ID: 26725021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.
    Robbins A; Hentzien M; Toquet S; Didier K; Servettaz A; Pham BN; Giusti D
    Front Immunol; 2019; 10():444. PubMed ID: 30915082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers.
    Röber N; Dellavance A; Ingénito F; Reimer ML; Carballo OG; Conrad K; Chan EKL; Andrade LEC
    Front Immunol; 2021; 12():730102. PubMed ID: 34675922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latest update on the Ro/SS-A autoantibody system.
    Schulte-Pelkum J; Fritzler M; Mahler M
    Autoimmun Rev; 2009 Jun; 8(7):632-7. PubMed ID: 19393201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
    González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
    Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA association of anti-Ro60 and anti-Ro52 antibodies in Sjögren's syndrome.
    Ricchiuti V; Isenberg D; Muller S
    J Autoimmun; 1994 Oct; 7(5):611-21. PubMed ID: 7530962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies.
    Strandberg L; Salomonsson S; Bremme K; Sonesson S; Wahren-Herlenius M
    Lupus; 2006; 15(6):346-53. PubMed ID: 16830880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease.
    Peene I; Meheus L; De Keyser S; Humbel R; Veys EM; De Keyser F
    Ann Rheum Dis; 2002 Oct; 61(10):929-33. PubMed ID: 12228166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell antibody nanowells: a novel technology in detecting anti-SSA/Ro60- and anti-SSB/La autoantibody-producing cells in peripheral blood of rheumatic disease patients.
    Esfandiary L; Gupta N; Voigt A; Wanchoo A; Chan EK; Sukumaran S; Nguyen CQ
    Arthritis Res Ther; 2016 May; 18(1):107. PubMed ID: 27184054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.
    Murng SHK; Thomas M
    J Clin Pathol; 2018 Jan; 71(1):12-19. PubMed ID: 28663326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common and specific associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies in systemic lupus erythematosus.
    Menéndez A; Gómez J; Caminal-Montero L; Díaz-López JB; Cabezas-Rodríguez I; Mozo L
    ScientificWorldJournal; 2013; 2013():832789. PubMed ID: 24294139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
    Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
    Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sera from patients with rheumatic diseases recognize different epitope regions on the 52-kD Ro/SS-A protein.
    Bozic B; Pruijn GJ; Rozman B; van Venrooij WJ
    Clin Exp Immunol; 1993 Nov; 94(2):227-35. PubMed ID: 7693382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
    Bettacchioli E; Saraux A; Tison A; Cornec D; Dueymes M; Foulquier N; Hillion S; Roguedas-Contios AM; Benyoussef AA; Alarcon-Riquelme ME; Pers JO; Devauchelle-Pensec V;
    Arthritis Rheumatol; 2024 May; 76(5):751-762. PubMed ID: 38130019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Zampeli E; Mavrommati M; Moutsopoulos HM; Skopouli FN
    Clin Exp Rheumatol; 2020; 38 Suppl 126(4):134-141. PubMed ID: 32083547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block.
    Fritsch C; Hoebeke J; Dali H; Ricchiuti V; Isenberg DA; Meyer O; Muller S
    Arthritis Res Ther; 2006; 8(1):R4. PubMed ID: 16356190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical associations of anti-SSA/Ro60 and anti-Ro52/TRIM21 antibodies: Diagnostic utility of their separate detection.
    Menéndez A; Gómez J; Escanlar E; Caminal-Montero L; Mozo L
    Autoimmunity; 2013 Feb; 46(1):32-9. PubMed ID: 23039326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Ro60 Seropositivity Determines Anti-Ro52 Epitope Mapping in Patients With Systemic Sclerosis.
    Gkoutzourelas A; Liaskos C; Mytilinaiou MG; Simopoulou T; Katsiari C; Tsirogianni A; Daoussis D; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
    Front Immunol; 2018; 9():2835. PubMed ID: 30581434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
    Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
    J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.